| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9945483 | The Annals of Thoracic Surgery | 2005 | 6 Pages |
Abstract
Recombinant factor VIIa was effective in restoring hemostasis, but thromboembolic complications occurred after rFVIIa use. They may be related to the underlying pathologies and surgery performed. It is possible, however, that rFVIIa treatment contributed to their occurrence.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Peter MD, Raili MD, PhD, Anne H. MD, PhD,